TRDX’s Medical & Dental Products Division Signs LOI Exclusive Licensing Rights for "SoleCare(R)," an Innovative, Patent Pending,…

JERICHO, NY–(Marketwire – August 3, 2010) – SciMeDent Health, Corp. f/k/a Trend Exploration, Inc. (“TRDX” or the “Company”) (PINKSHEETS: TRDX) today announces that Preferred Distribution, Inc., the Company’s medical and dental products subsidiary, has signed a Letter of Intent (“LOI”) to acquire the exclusive licensing rights to SoleCare®, an innovative, patent pending, podiatry product.

SoleCare® is a unique new product for the removal of calluses by pedicurists.

The Company expects the continuing negotiations to result in a definitive agreement in the near term.

Dr. Gary Wallach, the inventor of SoleCare®, stated: “I am very excited about the decision to work with SciMeDent on the development and distribution of my SoleCare line of products.”

Dr. Stahl, CEO of TRDX, commented: “We advanced our discussions from a distribution relationship to an exclusive license deal. Having a license makes us more of a partner with Dr. Wallach and the SoleCare® team.”

About SCIMEDENT f/k/a Trend Exploration, Inc. (PINKSHEETS: TRDX)

SciMeDent (www.scimedenthealth.com) is a company focused on being a leading developer and marketer of products and services for medicine, dentistry and life sciences. SciMeDent plans to achieve growth initially through mergers and acquisitions.

Cautionary Statement Regarding Forward-Looking Statements

A number of statements contained in this press release are forward-looking statements. These forward-looking statements involve a number of risks and uncertainties, including the sufficiency of existing capital resources, technological or industry changes and uncertainties related to the development of the Company’s business model. The actual results the Company may achieve could differ materially from any forward-looking statements due to such risks and uncertainties.